Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group
Hofheinz, Ralf‐Dieter, Hegewisch‐Becker, Susanne, Kunzmann, Volker, Thuss‐Patience, Peter, Fuchs, Martin, Homann, Nils, Graeven, Ullrich, Schulte, Nadine, Merx, Kirsten, Pohl, Michael, Held, Swantje, Keller, Ralph, Tannapfel, Andrea, Al‐Batran, Salah‐Eddin
Published in International journal of cancer (15.09.2021)
Published in International journal of cancer (15.09.2021)
Get full text
Journal Article
Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy
Goetze, Thorsten Oliver, Stein, Alexander, Lorenzen, Sylvie, Habibzada, Timorshah, Goekkurt, Eray, Herhaus, Peter, Loose, Maria, Sookthai, Disorn, Brulin, Tanita, Ihrig, Kristina, Pauligk, Claudia, Al-Batran, Salah-Eddin
Published in International journal of cancer (15.11.2023)
Published in International journal of cancer (15.11.2023)
Get full text
Journal Article
Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy
Masetti, Michael, Al‐Batran, Salah‐Eddin, Goetze, Thorsten O., Thuss‐Patience, Peter, Knorrenschild, Jorge Riera, Goekkurt, Eray, Folprecht, Gunnar, Ettrich, Thomas Jens, Lindig, Udo, Luley, Kim Barbara, Pink, Daniel, Dechow, Tobias, Sookthai, Disorn, Junge, Sabine, Loose, Maria, Pauligk, Claudia, Lorenzen, Sylvie
Published in International journal of cancer (15.06.2024)
Published in International journal of cancer (15.06.2024)
Get full text
Journal Article
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma
Lordick, Florian, Al-Batran, Salah-Eddin, Ganguli, Arijit, Morlock, Robert, Sahin, Ugur, Türeci, Özlem
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2021)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2021)
Get full text
Journal Article
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM
Goetze, Thorsten O., Hofheinz, Ralf‐Dieter, Gaiser, Timo, Schmalenberg, Harald, Strumberg, Dirk, Goekkurt, Eray, Angermeier, Stefan, Zander, Thomas, Kopp, Hans G., Pink, Daniel, Siegler, Gabriele, Schenk, Michael, Vita, Ferdinando, Galizia, Gennaro, Maiello, Evaristo, Bechstein, Wolf O., Elshafei, Moustafa, Loose, Maria, Sookthai, Disorn, Brulin, Tanita, Pauligk, Claudia, Homann, Nils, Al‐Batran, Salah‐Eddin
Published in International journal of cancer (01.07.2023)
Published in International journal of cancer (01.07.2023)
Get full text
Journal Article
Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510
Högner, Anica, Al‐Batran, Salah‐Eddin, Siveke, Jens T., Lorenz, Mario, Bartels, Prisca, Breithaupt, Kirstin, Malfertheiner, Peter, Homann, Nils, Stein, Alexander, Gläser, Dietrich, Tamm, Ingo, Hinke, Axel, Vogel, Arndt, Thuss‐Patience, Peter
Published in International journal of cancer (15.03.2022)
Published in International journal of cancer (15.03.2022)
Get full text
Journal Article
Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC)
Lorenzen, Sylvie, Knorrenschild, Jorge Riera, Pauligk, Claudia, Hegewisch‐Becker, Susanna, Seraphin, Jörg, Thuss‐Patience, Peter, Kopp, Hans‐Georg, Dechow, Tobias, Vogel, Arndt, Luley, Kim Barbara, Pink, Daniel, Stahl, Michael, Kullmann, Frank, Hebart, Holger, Siveke, Jens, Egger, Matthias, Homann, Nils, Probst, Stephan, Goetze, Thorsten Oliver, Al‐Batran, Salah‐Eddin
Published in International journal of cancer (01.11.2020)
Published in International journal of cancer (01.11.2020)
Get full text
Journal Article
Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review
Chiorean, Elena Gabriela, Cheung, Winson Y., Giordano, Guido, Kim, George, Al-Batran, Salah-Eddin
Published in Therapeutic Advances in Medical Oncology (2019)
Published in Therapeutic Advances in Medical Oncology (2019)
Get full text
Book Review
Journal Article
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
Al‐Batran, Salah‐Eddin, Hofheinz, Ralf‐Dieter, Reichart, Alexander, Pauligk, Claudia, Schönherr, Caroline, Schlag, Rudolf, Siegler, Gabriele, Dörfel, Steffen, Koenigsmann, Michael, Zahn, Mark‐Oliver, Schubert, Jörg, Aldaoud, Ali, Höffkes, Heinz‐Gert, Schulz, Holger, Hahn, Lars, Uhlig, Jens, Blau, Wolfgang, Stauch, Martina, Weniger, Jörg, Wolf, Martin, Jacobasch, Lutz, Bildat, Stephan, Wehmeyer, Jürgen, Homann, Nils, Trojan, Jörg, Waidmann, Oliver, Fietz, Thomas, Feustel, Hans‐Peter, Groschek, Matthias, Wierecky, Jan, Waibel, Karin, Mahlmann, Stefan, Schwindel, Uwe, Peters, Uwe, Schuch, Gunter, Pink, Daniel, Eschenburg, Henning, Wörns, Marcus‐A., Harich, Hans‐Detlev, Weikersthal, Ludwig Fischer, Däßler, Klaus‐Ulrich, Behringer, Dirk M., Messmann, Helmut, Kretzschmar, Albrecht, Gallmeier, Eike, Forstbauer, Helmut, Kunzmann, Volker, Papke, Jens, Büchner‐Steudel, Petra, Vehling‐Kaiser, Ursula, Springfeld, Christoph, Vogel, Arndt, Ettrich, Thomas J., Schaaf, Marina, Hausen, Gerrit zur, Götze, Thorsten Oliver
Published in International journal of cancer (15.03.2021)
Published in International journal of cancer (15.03.2021)
Get full text
Journal Article
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
Lordick, Florian, Al-Batran, Salah-Eddin, Arnold, Dirk, Borner, Markus, Bruns, Christiane J., Eisterer, Wolfgang, Faber, Gerhard, Gockel, Ines, Köberle, Dieter, Lorenzen, Sylvie, Möhler, Markus, Pritzkuleit, Ron, Stahl, Michael, Thuss-Patience, Peter, Wöll, Ewald, Zander, Thomas, Maschmeyer, Georg
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.01.2024)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.01.2024)
Get full text
Journal Article
Relevance of liver‐limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE‐3/AIO KRK0306 trial
Holch, Julian Walter, Ricard, Ingrid, Stintzing, Sebastian, Fischer von Weikersthal, Ludwig, Decker, Thomas, Kiani, Alexander, Vehling‐Kaiser, Ursula, Al‐Batran, Salah‐Eddin, Heintges, Tobias, Lerchenmüller, Christian, Kahl, Christoph, Kullmann, Frank, Scheithauer, Werner, Scholz, Michael, Müller, Sebastian, Link, Hartmut, Rost, Andreas, Höffkes, Heinz‐Gert, Moehler, Markus, Lindig, Reinhard Udo, Miller‐Phillips, Lisa, Kirchner, Thomas, Jung, Andreas, von Einem, Jobst Christian, Modest, Dominik Paul, Heinemann, Volker
Published in International journal of cancer (01.03.2018)
Published in International journal of cancer (01.03.2018)
Get full text
Journal Article
Relation of early tumor shrinkage (ETS) observed in first‐line treatment to efficacy parameters of subsequent treatment in FIRE‐3 (AIOKRK0306)
Modest, Dominik P., Stintzing, Sebastian, Fischer von Weikersthal, Ludwig, Decker, Thomas, Kiani, Alexander, Vehling‐Kaiser, Ursula, Al‐Batran, Salah‐Eddin, Heintges, Tobias, Lerchenmüller, Christian, Kahl, Christoph, Seipelt, Gernot, Kullmann, Frank, Scheithauer, Werner, Kirchner, Thomas, Jung, Andreas, Stauch, Martina, von Einem, Jobst Christian, Moehler, Markus, Held, Swantje, Heinemann, Volker
Published in International journal of cancer (15.04.2017)
Published in International journal of cancer (15.04.2017)
Get full text
Journal Article
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Le, Dung T, Kim, Tae Won, Van Cutsem, Eric, Geva, Ravit, Jäger, Dirk, Hara, Hiroki, Burge, Matthew, O'Neil, Bert, Kavan, Petr, Yoshino, Takayuki, Guimbaud, Rosine, Taniguchi, Hiroya, Elez, Elena, Al-Batran, Salah-Eddin, Boland, Patrick M, Crocenzi, Todd, Atreya, Chloe E, Cui, Yi, Dai, Tong, Marinello, Patricia, Diaz, Jr, Luis A, André, Thierry
Published in Journal of clinical oncology (01.01.2020)
Published in Journal of clinical oncology (01.01.2020)
Get full text
Journal Article
A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial
Kloor, Matthias, Reuschenbach, Miriam, Pauligk, Claudia, Karbach, Julia, Rafiyan, Mohammad-Reza, Al-Batran, Salah-Eddin, Tariverdian, Mirjam, Jäger, Elke, von Knebel Doeberitz, Magnus
Published in Clinical cancer research (01.09.2020)
Published in Clinical cancer research (01.09.2020)
Get full text
Journal Article
Prognostic and predictive value of estrogen receptor 1 expression in completely resected non‐small cell lung cancer
Brueckl, Wolfgang Michael, Al‐Batran, Salah‐Eddin, Ficker, Joachim Hans, Claas, Silke, Atmaca, Akin, Hartmann, Arndt, Rieker, Ralf Joachim, Wirtz, Ralph Markus
Published in International journal of cancer (15.10.2013)
Published in International journal of cancer (15.10.2013)
Get full text
Journal Article
Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer
Kim, Tae You, Yen, Chia-Jui, Al-Batran, Salah-Eddin, Ferry, David, Gao, Ling, Hsu, Yanzhi, Cheng, Rebecca, Orlando, Mauro, Ohtsu, Atsushi
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.03.2018)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.03.2018)
Get full text
Journal Article
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial
Stintzing, Sebastian, Dr, Modest, Dominik P, MD, Rossius, Lisa, Lerch, Markus M, Prof, von Weikersthal, Ludwig Fischer, MD, Decker, Thomas, MD, Kiani, Alexander, MD, Vehling-Kaiser, Ursula, MD, Al-Batran, Salah-Eddin, Prof, Heintges, Tobias, MD, Lerchenmüller, Christian, MD, Kahl, Christoph, MD, Seipelt, Gernot, MD, Kullmann, Frank, MD, Stauch, Martina, MD, Scheithauer, Werner, Prof, Held, Swantje, MSc, Giessen-Jung, Clemens, MD, Moehler, Markus, Prof, Jagenburg, Andreas, MD, Kirchner, Thomas, Prof, Jung, Andreas, Prof, Heinemann, Volker, Prof
Published in The lancet oncology (01.10.2016)
Published in The lancet oncology (01.10.2016)
Get full text
Journal Article
mTOR as a therapeutic target in patients with gastric cancer
Al-Batran, Salah-Eddin, Ducreux, Michel, Ohtsu, Atsushi
Published in International journal of cancer (01.02.2012)
Published in International journal of cancer (01.02.2012)
Get full text
Journal Article
Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial
Joensuu, Heikki, Eriksson, Mikael, Sundby Hall, Kirsten, Reichardt, Annette, Hartmann, Jörg T, Pink, Daniel, Ramadori, Giuliano, Hohenberger, Peter, Al-Batran, Salah-Eddin, Schlemmer, Marcus, Bauer, Sebastian, Wardelmann, Eva, Nilsson, Bengt, Sihto, Harri, Bono, Petri, Kallio, Raija, Junnila, Jouni, Alvegård, Thor, Reichardt, Peter
Published in Journal of clinical oncology (20.01.2016)
Published in Journal of clinical oncology (20.01.2016)
Get full text
Journal Article